[Severe combined immunodeficiency].
Kumaki
S
S
Department of Pediatric Oncology, Institute of Development, Aging and Cancer, Tohoku University.
Tsuchiya
S
S
D000818:Animals; D016026:Bone Marrow Transplantation; D004268:DNA-Binding Proteins; D003937:Diagnosis, Differential; D015316:Genetic Therapy; D018398:Homeodomain Proteins; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D053616:Janus Kinase 3; D017493:Leukocyte Common Antigens; D008214:Lymphocytes; D009687:Nuclear Proteins; D011379:Prognosis; D011505:Protein-Tyrosine Kinases / Q000172:deficiency; D020395:Receptors, Interleukin-7 / Q000172:deficiency; D016511:Severe Combined Immunodeficiency / Q000145:classification / Q000209:etiology; D019172:Transplantation Conditioning; D014960:X Chromosome
D004268:DNA-Binding Proteins; D018398:Homeodomain Proteins; D009687:Nuclear Proteins; C499311:RAG2 protein, human; D020395:Receptors, Interleukin-7; C064655:V(D)J recombination activating protein 2; C064658:RAG-1 protein; D011505:Protein-Tyrosine Kinases; C507933:JAK3 protein, human; D053616:Janus Kinase 3; D017493:Leukocyte Common Antigens